---
title: "Merck Says Intismeran Plus Keytruda Significantly Reduced Risk Of Recurrence Or Death By 42%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302764536.md"
datetime: "2026-10-22T18:42:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302764536.md)
  - [en](https://longbridge.com/en/news/302764536.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302764536.md)
generator: "portal-rs"
---

# Merck Says Intismeran Plus Keytruda Significantly Reduced Risk Of Recurrence Or Death By 42%

Oct 23 (Reuters) - Merck & Co Inc (MRK.N) :

-   MERCK & CO INC: INTISMERAN PLUS KEYTRUDA SIGNIFICANTLY REDUCED THE RISK OF RECURRENCE OR DEATH BY 42% COMPARED TO KEYTRUDA ALONE
-   MERCK & CO: SAFETY PROFILE OF INTISMERAN PLUS KEYTRUDA WAS GENERALLY CONSISTENT WITH PREVIOUSLY REPORTED STUDIES OF COMBINATION
-   MERCK: INTISMERAN PLUS KEYTRUDA REDUCED RISK OF RECURRENCE OR DEATH BY 58% COMPARED TO KEYTRUDA ALONE
-   MERCK & CO: IN PHASE 3 INTERPATH-001 TRIAL NO NEW SAFETY SIGNALS WERE OBSERVED
-   MERCK: OVERALL SURVIVAL DATA ARE NOT YET MATURE, BUT FAVORABLE TREND IN OS WITH INTISMERAN PLUS KEYTRUDA HAS BEEN OBSERVED
-   MERCK: INTISMERAN PLUS KEYTRUDA SIGNIFICANTLY REDUCED RISK OF DISTANT METASTASIS OR DEATH BY 38% VERSUS KEYTRUDA ALONE
-   MERCK: INTISMERAN PLUS KEYTRUDA REDUCED RECURRENCE/DEATH RISK BY 58%, REDUCED RISK OF DISTANT METASTASIS/DEATH BY HALF AT 6 MONTHS VERSUS KEYTRUDA ALONE

Further company coverage: (MRK.N)

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [What Is Merck (MRK) Betting On With Its $2.13 Billion KRAS Deal?](https://longbridge.com/en/news/300416193.md)
- [Merck's experimental eye drug meets goal in trial, but raises safety concerns](https://longbridge.com/en/news/301512275.md)
- [Results: Billerud AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates](https://longbridge.com/en/news/302983070.md)
- [What to expect from Custom Truck One Source’s (CTOS) Q3 earnings](https://longbridge.com/en/news/302975983.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**